Bioequivalence Evaluation of Narrow Therapeutic Index Drugs - Rationales for the Current Regulatory Approach by U.S. FDA
Author/sJiang, Wenlei
Date:09/29/2022
Meeting Name:5th Annual Global Bioequivalence Harmonization Initiative Meeting
State:Netherlands
City:Amsterdam